Arcellx, Inc (NASDAQ:ACLX) Poised For Near-Term Repricing Following Strategic Acquisition Interest
Clinical readouts and takeover activity have pushed valuation into the spotlight, leaving price momentum strong but vulnerable to momentum-based pullbacks. Near-term movement should reflect deal-related flows and technical exhaustion signals.









